EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access

Global Diabetes Prevalence in COVID-19 Patients and Contribution to COVID-19– Related Severity and Mortality: A Systematic Review and Meta-analysis

Rui Li, Mingwang Shen, Qianqian Yang, Christopher K Fairley, Zhonglin Chai iD, Robert McIntyre, Jason J Ong, Hanting Liu, Pengyi Lu, Wenyi Hu, Zhuoru Zou, Zengbin Li und 3 weitere

Diabetes Care · 01.04.2023 · 46 (4) · 890-897

DOI: 10.2337/dc22-1943 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Diabetes Care, online erschienen am 23.03.2023. Verfasst von Rui Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaan…. Hauptthemen laut MEDLINE: COVID-19, Diabetes Mellitus. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Bill & Melinda Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND COVID-19 and diabetes both contribute to large global disease burdens. PURPOSE To quantify the prevalence of diabetes in various COVID-19 disease stages and calculate the population attributable fraction (PAF) of diabetes to COVID-19–related severity and mortality. DATA SOURCES Systematic review identified 729 studies with 29,874,938 COVID-19 patients. STUDY SELECTION Studies detailed the prevalence of diabetes in subjects with known COVID-19 diagnosis and severity. DATA EXTRACTION Study information, COVID-19 disease stages, and diabetes prevalence were extracted. DATA SYNTHESIS The pooled prevalence of diabetes in stratified COVID-19 groups was 14.7% (95% CI 12.5–16.9) among confirmed cases, 10.4% (7.6–13.6) among nonhospitalized cases, 21.4% (20.4–22.5) among hospitalized cases, 11.9% (10.2–13.7) among nonsevere cases, 28.9% (27.0–30.8) among severe cases, and 34.6% (32.8–36.5) among deceased individuals, respectively. Multivariate metaregression analysis explained 53–83% heterogeneity of the pooled prevalence. Based on a modified version of the comparative risk assessment model, we estimated that the overall PAF of diabetes was 9.5% (7.3–11.7) for the presence of severe disease in COVID-19–infected individuals and 16.8% (14.8–18.8) for COVID-19–related deaths. Subgroup analyses demonstrated that countries with high income levels, high health care access and quality index, and low diabetes disease burden had lower PAF of diabetes contributing to COVID-19 severity and death. LIMITATIONS Most studies had a high risk of bias. CONCLUSIONS The prevalence of diabetes increases with COVID-19 severity, and diabetes accounts for 9.5% of severe COVID-19 cases and 16.8% of deaths, with disparities according to country income, health care access and quality index, and diabetes disease burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Diabetes MellitusHumansPrevalenceCOVID-19 TestingRisk Assessment

Autor:innen und Institutionen

  • China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
  • Melbourne Sexual Health Centre, Alfred Health, Melbourne, Australia.
  • Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.
  • Key Laboratory for Disease Prevention and Control and Health Promotion of Shaanxi Province, Xi'an, Shaanxi, China.
  • Department of Diabetes, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
  • Bariatric and Metabolic Surgery, King's College Hospital, London, U.K.

ORCID-Profile: Zhonglin Chai, Lei Zhang

Förderung

  • Bill & Melinda Gates Foundation

Zitieren

APA

Li, R., Shen, M., Yang, Q., Fairley, C. K., Chai, Z., McIntyre, R., Ong, J. J., Liu, H., Lu, P., Hu, W., Zou, Z., Li, Z., He, S., Zhuang, G., & Zhang, L. (2023). Global Diabetes Prevalence in COVID-19 Patients and Contribution to COVID-19– Related Severity and Mortality: A Systematic Review and Meta-analysis. Diabetes Care, 46(4), 890-897. https://doi.org/10.2337/dc22-1943

Vancouver

Li R, Shen M, Yang Q, Fairley CK, Chai Z, McIntyre R, et al. Global Diabetes Prevalence in COVID-19 Patients and Contribution to COVID-19– Related Severity and Mortality: A Systematic Review and Meta-analysis. Diabetes Care. 2023;46(4):890-897. doi:10.2337/dc22-1943

BibTeX
@article{Li2023,
  author = {Li, Rui and Shen, Mingwang and Yang, Qianqian and Fairley, Christopher K and Chai, Zhonglin and McIntyre, Robert and Ong, Jason J and Liu, Hanting and Lu, Pengyi and Hu, Wenyi and Zou, Zhuoru and Li, Zengbin and He, Shihao and Zhuang, Guihua and Zhang, Lei},
  title = {Global Diabetes Prevalence in COVID-19 Patients and Contribution to COVID-19– Related Severity and Mortality: A Systematic Review and Meta-analysis},
  journal = {Diabetes Care},
  year = {2023},
  volume = {46},
  number = {4},
  pages = {890--897},
  doi = {10.2337/dc22-1943}
}
Kostenlos starten →